biOasis Technologies Ord Shs V.BTI.H

Alternate Symbol(s): BIOAF

Healthcare Biotechnology

Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in particular biological products, across the blood-brain barrier (BBB). It is focused on both orphan drug indications, including brain cancers, and rare genetic neurodegenerative diseases and neuroinflammatory conditions. The Company is also focused on its Epidermal Growth Factor (EGF) platform for treating rare and orphan neurodegenerative and neuroinflammatory disorders. EGF is a protein that stimulates cell growth and differentiation, notably for myelin producing cells. Its development programs include xB3-001: Brain Metastases, xB3-002: Glioblastoma and xB3-007: Neurodegenerative Disease.

TSXV:BTI.H - Post by User

biOasis Technologies Ord Shs

Bullboard Posts

Comment by dexter08on Jun 04, 2013 4:32pm

106 Views

Post# 21483044

RE: RE: "Sparse new-drug pipeline"

Well another down day should be below a buck soon...Either the latest tests which seem too have been going forever are not good or maybe they can't get the IP protection they need someone with a lot of shares has been unloading daily for months under anon...I guess that's how the rich get richer.....time will tell what the problems are charts don't lie!

Bullboard Posts

BMO evolves InvestorLine with enhanced tools for options trading